Tevogen Inc. Increase (Decrease) in Accounts Payable, Trade
Tevogen Inc. (TVGN) reported Increase (Decrease) in Accounts Payable, Trade of $458.47 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-05-15
- Tevogen Inc. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was $458.47K.
- Tevogen Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was $28.20K.
- Tevogen Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was -$1.03M.
- Tevogen Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-06-30 was -$424.44K, a 129.18% decline year-over-year.
- Tevogen Inc. increase (decrease) in accounts payable, trade for fiscal 2025 was -$1.96M, a 216.52% decline from fiscal 2024.
- Tevogen Inc. increase (decrease) in accounts payable, trade for fiscal 2024 was $1.69M, a 51.28% increase from fiscal 2023.
- Tevogen Inc. increase (decrease) in accounts payable, trade for fiscal 2023 was $1.11M.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2026-03-31 | $458.47K 10-Q · filed 2026-05-15 | $486.67K derived: sum of 2 quarters · filed 2026-05-15 | -$545.70K derived: sum of 3 quarters · filed 2026-05-15 | -$970.15K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | $28.20K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.00M derived: sum of 2 quarters · filed 2026-03-31 | -$1.43M derived: sum of 3 quarters · filed 2026-03-31 | -$1.96M 10-K · filed 2026-03-31 |
| 2025-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$1.46M derived: sum of 2 quarters · filed 2025-11-14 | -$1.99M 10-Q · filed 2025-11-14 | -$2.63M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | -$424.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$959.94K 10-Q · filed 2025-08-14 | -$1.60M derived: sum of 3 quarters · filed 2026-05-15 | -$2.43M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | -$535.50K 10-Q · filed 2026-05-15 | -$1.17M derived: sum of 2 quarters · filed 2026-05-15 | -$2.00M derived: sum of 3 quarters · filed 2026-05-15 | -$547.15K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$638.12K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.47M derived: sum of 2 quarters · filed 2026-03-31 | -$11.65K derived: sum of 3 quarters · filed 2026-03-31 | $1.69M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$827.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $626.46K derived: sum of 2 quarters · filed 2025-11-14 | $2.32M 10-Q · filed 2025-11-14 | $2.67M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $3.15M 10-Q · filed 2025-08-14 | $3.50M derived: sum of 3 quarters · filed 2025-08-14 | $3.89M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $1.70M 10-Q · filed 2025-05-14 | $2.05M derived: sum of 2 quarters · filed 2025-05-14 | $2.44M derived: sum of 3 quarters · filed 2025-05-14 | $2.31M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $349.63K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $741.65K derived: sum of 2 quarters · filed 2025-04-02 | $616.78K derived: sum of 3 quarters · filed 2025-04-02 | $1.11M 10-K · filed 2025-04-02 |
| 2023-09-30 | $392.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $267.15K derived: sum of 2 quarters · filed 2024-11-19 | $764.64K 10-Q · filed 2024-11-19 | |
| 2023-06-30 | -$124.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $372.61K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $497.48K 10-Q · filed 2024-05-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B |